PRIORITIES OF EARLY PATHOGENETIC THERAPY OF FLUE AND SARS OF OTHER ETIOLOGY

Abstract

The prevalence of influenza and acute respiratory viral infections, high frequency of complications with a high mortality rate in certain groups of the population, short duration of specific immunity and the lack of efficiency of use of antiviral drugs for the treatment of patients make the problem of rational pathogenetic therapy of respiratory infections extremely urgent. The excessive local inflammatory reaction in response to the penetration of the pathogen of SARS in the body can lead to massive death of the tissue and rapid systemic spread of the infectious agent. Treatment of patients with influenza should be based on the likely dynamics of the onset of symptoms, development of complications and severe disturbances of the vital organs.According to the principle of step by step treatment, any «influenza infection» must be regarded as a potentially serious illness that threatens the patient serious complications. Even with normal flu symptoms from the first hours from the onset of the disease, it is advisable to prescribe combination of the antiviral and pathogenetic therapy. A combination of antiviral, antipyretic, anti-inflammatory and antioxidant therapy at an early stage in most cases allows limitation of the development of severe forms of the disease and death prevention.

Keywords

• influenza
• acute respiratory viral infection
• pathogenetic therapy
• anti-inflammatory therapy
• antipyretic therapy
• antioxidant therapy
• acetaminophen
• theraflu